Fineotex Chemical Limited has informed the Exchange about Transcript of Investor/Analyst meet held on May 18, 2026 at 10.00 AM.
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fineotex Chemical reported Q4 FY2025-26 revenue of INR 314 crores (up 162% YoY) and PAT of INR 44 crores (up 118% YoY), driven by strong performance across all three business segments and the newly acquired CrudeChem Technologies Group. International revenue now accounts for 70% of total revenue, reflecting the company's global diversification. The company has revised its CrudeChem revenue target from $200 million by 2030 to achieving it before 2028, with Q4 run rate already at ~$90-100 million. Management guided for blended EBITDA margins of 18-20% (from current 14%), indicating margin improvement expectations. The CFO stated Q4 numbers serve as a baseline, with potential for revenue to grow 3-4x in 3-4 years, implying INR 3,000+ crore revenue trajectory.
The strong Q4 results and upward revision in CrudeChem growth timeline signal accelerated value creation from the December 2025 acquisition. Management's confidence in achieving 18-20% EBITDA margins demonstrates operational leverage, while the $3.5-4 billion North American addressable market provides significant growth runway. The company remains debt-free with INR 300+ crore cash on books, positioning it well for further acquisitions.